Vaishali Pharma: FY19-20 revenue dips at Rs.62.25 crore against Rs.77.07 crore YoY.

Company : Vera Synthetic Limited

Standalone total revenue for HY2 of FY2019-20 at Vaishali Pharma stood at Rs.32.81 crore and Rs.29.44 crore in HY1

Standalone net loss for the HY2 of FY2019-20 reached Rs.55.16 lacs while in HY1 it was PAT which stood Rs.58.44 lacs.

Loss per share for current half year ended on 31st March 20 was Rs.0.52 against Rs.0.55 in the previous HY period.

Following are the financials of the recently concluded FY2019-20 at Vaishali Pharma:

• Revenue was Rs.62.25 crore whereas preceding year it was Rs.77.07 crore.

• PBT stands at Rs.7.91 lacs as compared to Rs.1.13 crore a year ago.

• PAT reached Rs.3.28 lacs as compared to Rs.71.36 lacs a year ago.

• EPS stands at Rs.0.03 whereas in previous year it was Rs.0.68

Recent Stories